These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3120466)

  • 41. Biochemical diagnosis in sickle cell disease.
    Isaacs WA
    Ghana Med J; 1971 Mar; 10(1):40-3. PubMed ID: 5173734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pros and cons of the fourth revision of thalassaemia screening programme in Iran.
    Moafi A; Vallian R; Vallian S; Rahgozar S; Torfenajad M; Moafi H
    J Med Screen; 2017 Mar; 24(1):1-5. PubMed ID: 26992783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A center in Paris for screening and counselling sickle cell patients and carriers].
    Tchernia G; Bardakdjian J; Lainé A; Ly A; Orssaud G; Larnaudie S
    Bull Acad Natl Med; 2008 Oct; 192(7):1349-59; discussion 1359-60. PubMed ID: 19445361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sickling syndromes in children.
    Honig GR
    Adv Pediatr; 1976; 23():271-313. PubMed ID: 795281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on sickle cell heterozygotes in Saudi Arabia--interaction with alpha-thalassaemia.
    el-Hazmi MA
    Acta Haematol; 1986; 75(2):100-4. PubMed ID: 3090815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haematological status of blood-donors with sickle cell trait and alpha thalassaemia in northern Nigeria.
    Niazi GA; Fleming AF
    East Afr Med J; 1989 Dec; 66(12):824-9. PubMed ID: 2612414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires.
    Dyson SM; Culley L; Gill C; Hubbard S; Kennefick A; Morris P; Rees D; Sutton F; Squire P
    Ethn Health; 2006 May; 11(2):169-89. PubMed ID: 16595318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of thalassaemia major.
    Modell B; Petrou M
    Arch Dis Child; 1983 Dec; 58(12):1026-30. PubMed ID: 6660889
    [No Abstract]   [Full Text] [Related]  

  • 49. Reflections on the current status of the national sickle cell disease program in the United States.
    Scott RB
    J Natl Med Assoc; 1979 Jul; 71(7):679-81. PubMed ID: 529329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-thalassaemia control.
    Zorcolo G; Landis N; Madeddu E; Mandas G; Montaldo E; Perisi S; Piras G; Salemi L; Sicilia R
    Lancet; 1986 Jul; 2(8498):103. PubMed ID: 2873360
    [No Abstract]   [Full Text] [Related]  

  • 51. Prenatal diagnosis of hemoglobinopathies. A review of 15 cases.
    Alter BP; Modell CB; Fairweather D; Hobbins JC; Mahoney MJ; Frigoletto FD; Sherman AS; Nathan DG
    N Engl J Med; 1976 Dec; 295(26):1437-43. PubMed ID: 995141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community control of hereditary anaemias: memorandum from a WHO meeting.
    Bull World Health Organ; 1983; 61(1):63-80. PubMed ID: 6601544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
    Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
    Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for abnormal hemoglobins: who, when, and how.
    McCurdy PR
    Prim Care; 1980 Sep; 7(3):451-60. PubMed ID: 6905205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sickle cell-Hb Lepore Boston syndrome. Uncommon differential diagnosis to homozygous sickle cell disease.
    Stevens MC; Lehmann H; Mason KP; Serjeant BE; Serjeant GR
    Am J Dis Child; 1982 Jan; 136(1):19-22. PubMed ID: 7055103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemoglobinopathy screening: an end to institutional racism?
    Marteau T; Dormandy E
    Br J Gen Pract; 2005 Jun; 55(515):419-20. PubMed ID: 15970062
    [No Abstract]   [Full Text] [Related]  

  • 57. Sickle cell traits in Canada. Trimodal distribution of Hb S as a result of interaction with alpha-thalassaemia gene.
    Wong SC; Ali MA; Boyadjian SE
    Acta Haematol; 1981; 65(3):157-63. PubMed ID: 6165216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the national prevention program in iran, 2007-2009: the accomplishments and challenges with reflections on the path ahead.
    Hadipour Dehshal M; Tabrizi Namini M; Ahmadvand A; Manshadi M; Sadeghian Varnosfaderani F; Abolghasemi H
    Hemoglobin; 2014; 38(3):179-87. PubMed ID: 24669933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sickle cell syndromes. III. Silent-carrier alpha-thalassemia in combination with hemoglobin S and hemoglobin C.
    Honig GR; Mason RG; Tremaine LM; Vida LN
    Pediatr Res; 1979 Oct; 13(10):1109-11. PubMed ID: 503635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.